Skip to content

Arsenicum album â?? 30 as prophylactic for Covid-19

Effectiveness of Arsenicum Album 30c in Prevention of Covid-19 in Individuals Residing in Hot Spots of Red Zonesâ?? A Multicentric, Randomised, Cluster Level, Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025205
Enrollment
33000
Registered
2020-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Arsenicum album 30C: The Arsenicum album 30C will be given to the high risk contact of COVID 19 cases and residing in hotspots of containment zone. The 4 pills of medicine will be given

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • High risk contacts of Covid 19 infection who are asymptomatic and residing in hotspots. • Age 1 year & above • Both gender • Willing to give verbal informed consent or written informed consent as the situation may be (keeping in view contagious nature of disease)

Exclusion criteria

Exclusion criteria: • Pregnant women or lactating mothers • Immunocompromised individuals on basis of medical history. • Symptomatic (similar to COVID-19) cases at quarantine zone. • Not willing to give informed consent/verbal consent.

Design outcomes

Primary

MeasureTime frame
1. Confirmation of diagnosis for COVID-19 infection based on RT-PCR / end of quarantine period as per standard protocol.Timepoint: Every third day till 21st day.

Secondary

MeasureTime frame
1. To compare the asymptomatic/symptomatic Covid-19 positive cases between the groups. 2. To compare time to appearance of clinical symptoms of COVID-19 infections. 3. To compare time to confirmation of diagnosis for COVID-19 (Laboratory findings) Timepoint: Every third day till 21st day.

Countries

India

Contacts

Public ContactDr Debadatta Nayak

CCRH

drdnayak@gmail.com09873404012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026